Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) Invested Capital: 2019-2024

Historic Invested Capital for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to $150.8 million.

  • MDxHealth's Invested Capital rose 49.23% to $75.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $237.9 million, marking a year-over-year change of. This contributed to the annual value of $150.8 million for FY2024, which is 22.14% up from last year.
  • According to the latest figures from FY2024, MDxHealth's Invested Capital is $150.8 million, which was up 22.14% from $123.4 million recorded in FY2023.
  • In the past 5 years, MDxHealth's Invested Capital ranged from a high of $156.0 billion in FY2022 and a low of $28.6 million during FY2020.
  • For the 3-year period, MDxHealth's Invested Capital averaged around $39.1 billion, with its median value being $137.1 million (2023).
  • Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 152.58% in 2021, then dropped by 7.20% in 2023.
  • MDxHealth's Invested Capital (MRY) stood at $28.6 million in 2020, then surged by 152.58% to $72.3 million in 2021, then soared by 59.19% to $115.2 million in 2022, then rose by 7.20% to $123.4 million in 2023, then grew by 22.14% to $150.8 million in 2024.
  • Its Invested Capital stands at $150.8 million for FY2024, versus $123.4 million for FY2023 and $115.2 million for FY2022.